Results 31 to 40 of about 158,411 (308)

Sinovenous Thrombosis: Anticoagulation Therapy

Pediatric Neurology Briefs, 1998
The value of anticoagulant therapy in a consecutive cohort 5 year study of 30 children with 32 episodes of sinovenous thrombosis (SVT) was assessed at the Hospital for Sick Children, Toronto, Canada.
J Gordon Millichap
doaj   +1 more source

Clinical benefits and risks of anticoagulation therapy according to the degree of chronic kidney disease in patients with atrial fibrillation

BMC Cardiovascular Disorders, 2023
Background The clinical benefits and risks of anticoagulation therapy in patients with chronic kidney disease (CKD) are still inconclusive. We describe the outcomes of patients with atrial fibrillation (AF) after anticoagulation therapy according to ...
Min Soo Cho, Hyung Oh Choi, Ki Won Hwang, Jun Kim, Gi-Byoung Nam, Kee-Joon Choi   +5 more
doaj   +1 more source

Outpatient and inpatient anticoagulation therapy and the risk for hospital admission and death among COVID-19 patients

EClinicalMedicine, 2021
Background: Coronavirus disease 2019 (COVID-19) is associated with a hypercoagulable state. Limited data exist informing the relationship between anticoagulation therapy and risk for COVID-19 related hospitalization and mortality.
Sameh M. Hozayen, Diana Zychowski, Sydney Benson, Pamela L. Lutsey, Jasmin Haslbauer, Alexandar Tzankov, Zachary Kaltenborn, Michael Usher, Surbhi Shah, Christopher J. Tignanelli, Ryan T. Demmer   +10 more
doaj   +1 more source

Contrast-induced acute kidney injury and renal support for acute kidney injury : a KDIGO summary (part 2) [PDF]

, 2013
Acute kidney injury (AKI) is a common and serious problem affecting millions and causing death and disability for many. In 2012, Kidney Disease: Improving Global Outcomes completed the first ever international multidisciplinary clinical practice ...
Kellum, John A, Lameire, Norbert
core   +2 more sources

Low-Intensity vs. High-Intensity Antithrombotic Therapy After Transcatheter Aortic Valve Replacement: Meta-Analysis of Randomized Controlled Trials

Structural Heart, 2023
Background: The optimal antithrombotic therapy after transcatheter aortic valve replacement (TAVR) is controversial. We performed a systematic review and meta-analysis of randomized controlled trials comparing high-intensity vs.
Tarun Chakravarty, MD, Derek Leong, MD, Angelo de la Rosa, MD, Neel Bhardwaj, BS, Raj R. Makkar, MD   +4 more
doaj   +1 more source

Hepatic artery thrombosis after pediatric liver transplantation a medical or surgical event [PDF]

, 1989
Hepatic artery thrombosis (HAT) is one of the most serious complications after orthotopic liver transplan¬tation, and is associated with a high morbidity and mor¬tality.
Andrei, CS, Andres, GT, Baburao, K, Carlos, E, Delawir, K, Leonard, M, Satoru, T, Steven, B, Thomas, ES, Velma, PS, Vincenzo, M   +10 more
core   +1 more source

Extended Anticoagulation After Pulmonary Embolism: A Multicenter Observational Cohort Analysis

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Pulmonary embolism (PE) has a long‐term risk of adverse events, which can be prevented by extended anticoagulation. We compared clinical characteristics and outcomes between patients treated with 2‐year extended anticoagulation and those who ...
Romain Chopard, Ida Ehlers Albertsen, Fiona Ecarnot, Sebastien Guth, Matthieu Besutti, Nicolas Falvo, Gregory Piazza, Nicolas Meneveau   +7 more
doaj   +1 more source

Major Outcomes in Atrial Fibrillation Patients with One Risk Factor: Impact of Time in Therapeutic Range [PDF]

, 2016
BACKGROUND: The benefits and harms of oral anticoagulation (OAC) therapy in patients with only one stroke risk factor (i.e. CHA2DS2-VASc= 1 in males, or 2 in females) has been subject of debate.
Lip, Gregory Y. H., Proietti, Marco
core   +2 more sources

Legal and professional implications of shared care: a case study in oral anticoagulation stroke prevention therapy. [PDF]

, 2015
Policy initiatives and technological advances enable the use of integrated shared care models of healthcare delivery whereby the focus of care is moved from the hospital to the community, and also of models where patients take increasing responsibility ...
Coleman, B, Nicholls, JA, Patterson, DL, Potts, HW   +3 more
core   +1 more source

Pathways for lower extremity superficial vein thrombosis management in an academic medical center

Bleeding, Thrombosis and Vascular Biology
There is currently no established management pathway for lower extremity superficial vein thrombosis (SVT), leading to significant uncertainty among front-line providers.
Gisoo Imani, Aaron Wilson, Sara Vazquez, Daniel M. Witt   +3 more
doaj   +3 more sources